AstraZeneca's CEO justifies plans to supply the COVID-19 vaccine to UK ahead of EU

Moderna "Remains On Track" to Deliver 200m COVID-19 Vaccine Doses to the US Government by End of June 2021

GenTegra Touts Study On Novel SARS CoV-2 Saliva Collection Devices

Antibody Bamlanivimab, Administered with Etesevimab Reduced Risk of COVID-19 Hospitalizations and Death by 70%, Study Shows

Immunicum granted FDA Orphan Drug Designation for ilixadencel in STS

TScan Therapeutics Raises USD 100m in Series C Financing

Genentech's Faricimab Meets Primary Endpoint in Two Global Phase III Studies

Biologics License Application Accepted in China for Sylvant

Tevogen Bio supports clinical trials of investigational curative T cell therapy for COVID-19 under HMP Partners funding

Rizvi Named CEO at KSQ Therapeutics

US FDA Approval of Cabometyx in Combination with Opdivo as a First-Line Treatment for Patients with Advanced Renal Cell Carcinoma

FDA Approves Aurinia Pharmaceuticals' Lupkynis for Adult Patients with Active Lupus Nephritis

P and G Licenses Rhinostics Nasal Swab to Improve Speed of COVID-19 Testing

Boston Scientific wins FDA approval for Vercise Genus Deep Brain Stimulation System to treat symptoms of Parkinson's disease (PD)

Aurinia receives FDA's approval for LUPKYNIS for treating adult patients with Active Lupus Nephritis